Saturday 17 October 2026 Export OMDA’s income statement to Excel — free account

Omada Health, Inc.

OMDA Healthcare Health Information Services

Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024. In the quarter to June 2026, revenue grew 43.1%, EPS grew 137.5% and free cash flow grew 45.7%, each against the same quarter a year earlier.

17.63 1.04 −5.57%

Follow OMDA

Alert me

Market cap: $1.1B
P/E: 252×
Fwd P/E: 143×
Dividend yield: —
F-score: n/a
Altman Z: 3.98
Beneish M: −2.59
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 12.27

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	3	1	—	2	1	—	14	5	7	5	1

Insider Ownership 16.66%

Capital & Financial Ratios $m

Market Cap 1,140.00

Revenue 309.76

Net Income 4.31

Free Cash Flow 17.13

Net Debt (221.71)

Current Ratio 3.91

Debt/Equity 0.00

P/E ratio 251.86

Fwd P/E 143.00

P/S ratio 3.40

P/B ratio 4.16

Past 5Y EPS Growth —

This Y EPS Growth 193.88%

Next Y EPS Growth 35.82%

Next Y revenue growth 30.16%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	—	76	222	222
Receivables	—	23	35	57
Inventory	—	3	4	4
Other	—	—	—	—
	—	113	273	295

	2023	2024	2025	Q'26
Payables	—	4	10	12
ST’ Debt	—	—	—	—
Other	—	—	—	—
	—	54	76	75

Compound Annual Growth %

	10y	5y	3y
Sales	—	—	—
Cash Flow	—	—	—
Earnings	—	—	—
Book Value	—	—	—

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	78	88	—	—	—
’25	55	61	68	76	260
’24	—	41	46	—	170

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(12)	4	—	—	—
’25	(16)	3	10	21	18
’24	—	(29)	1	(6)	(34)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(13)	2	—	—	—
’25	(17)	2	8	20	12
’24	—	(31)	0	(7)	(38)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(0.05)	0.08	—	—	—
’25	(1.15)	(0.24)	(0.06)	0.08	(0.35)
’24	—	(1.40)	(1.18)	—	(6.10)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	—	—	—	—	14.14	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	—	—	—	—	28.40
People
People	Employees	—	—	—	—	—	—	—	—	—	916
	Revenue/emp, $m	—	—	—	—	—	—	—	0.00	0.00	0.28
Income, $m
Income, $m	Revenue	—	—	—	—	—	—	—	123	170	260
	Gross margin, %	—	—	—	—	—	—	—	56.99	60.59	65.69
	EBT	—	—	—	—	—	—	—	(68)	(47)	(13)
	EBT margin, %	—	—	—	—	—	—	—	(54.98)	(27.76)	(4.91)
	Net income	—	—	—	—	—	—	—	(68)	(47)	(13)
	Depreciation	—	—	—	—	—	—	—	7	8	9
Per share, $
Per share, $	Revenue	—	—	—	—	—	—	—	17.32	21.99	7.10
	Earnings	—	—	—	—	—	—	—	(9.52)	(6.10)	(0.35)
	Cash flow	—	—	—	—	—	—	—	(7.01)	(4.43)	0.50
	Capex	—	—	—	—	—	—	—	(0.41)	(0.50)	(0.16)
	Free cash flow	—	—	—	—	—	—	—	(7.43)	(4.93)	0.34
	Book value	—	—	—	—	—	—	—	0.00	(49.79)	6.27
	Shares, m	—	—	—	—	—	—	—	7	8	37
Valuation, ×
Valuation, ×	P/E	—	—	—	—	—	—	—	0.00	0.00	0.00
	P/S	—	—	—	—	—	—	—	0.00	0.00	2.22
	P/B	—	—	—	—	—	—	—	0.00	0.00	2.52
	EV/Sales	—	—	—	—	—	—	—	0.00	0.00	1.48
	EV/FCF	—	—	—	—	—	—	—	(2.58)	(2.58)	31.09
Cash, $m
Cash, $m	Operating cash flow	—	—	—	—	—	—	—	(50)	(34)	18
	Capex	—	—	—	—	—	—	—	(3)	(4)	(6)
	Free cash flow	—	—	—	—	—	—	—	(53)	(38)	12
Balance, $m
Balance, $m	Working capital	—	—	—	—	—	—	—	—	59	197
	Total debt	—	—	—	—	—	—	—	—	30	—
	Net debt	—	—	—	—	—	—	—	—	(47)	(222)
	Shareholders’ equity	—	—	—	—	—	—	—	—	(384)	230
Returns, %
Returns, %	ROA	—	—	—	—	—	—	—	0.00	(62.48)	(5.60)
	ROIC	—	—	—	—	—	—	—	0.00	0.00	(97.89)
	ROE	—	—	—	—	—	—	—	0.00	0.00	16.52

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
SDGR Schrodinger, Inc.	$1.9B	— (loss-making)	— (loss-making)	+7.54% (above 0%: growing)	n/m	+34.43% (above 0%: growing)	55.07%	(70.55%)	Compare
OMCL Omnicell, Inc.	$1.6B	41.6×	55.1×	+7.45% (above 0%: growing)	+341.67% (above 0%: growing)	+107.90% (above 0%: growing)	48.98%	10.39%	Compare
CERT Certara, Inc.	$1.5B	— (loss-making)	— (loss-making)	+0.99% (above 0%: growing)	n/m	−78.46% (below 0%: shrinking)	62.34%	(0.21%)	Compare
GDRX GoodRx Holdings, Inc.	$1.2B	62.7×	30.9×	−1.31% (below 0%: shrinking)	−25.00% (below 0%: shrinking)	+112.45% (above 0%: growing)	89.52%	11.79%	Compare
OMDA Omada Health, Inc.	$1.1B	252×	143×	+43.12% (above 0%: growing)	n/m	+45.71% (above 0%: growing)	72.62%	4.04%
TDOC Teladoc Health, Inc.	$1.1B	— (loss-making)	— (loss-making)	−3.95% (below 0%: shrinking)	n/m	−27.07% (below 0%: shrinking)	68.56%	(6.11%)	Compare
HSTM HealthStream, Inc.	$1.0B	46.0×	34.4×	+12.55% (above 0%: growing)	+27.78% (above 0%: growing)	+362.71% (above 0%: growing)	65.35%	9.94%	Compare
PHR Phreesia, Inc.	$685.3M	64.4×	23.5×	+10.41% (above 0%: growing)	+200.00% (above 0%: growing)	+43.51% (above 0%: growing)	66.64%	5.88%	Compare
MDRX Veradigm Inc.	$654.5M	— (loss-making)	— (loss-making)	−9.74% (below 0%: shrinking)	n/m	−66.33% (below 0%: shrinking)	50.53%	(37.41%)	Compare
Median of peers	$1.1B	54.4×	32.7×	+4.22%	+113.89%	+38.97%	63.85%	2.84%

All 51 Health Information Services stocks →

Omada Health, Inc. (OMDA) key facts

Strength: Omada Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $260.2 million, up 53.2% from fiscal 2024.
Omada Health, Inc. (OMDA) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, OMDA traded at $17.63, a market capitalization of $1.1 billion.
Return on equity was 16.5% and debt-to-equity 0.00.
Its Altman Z-score is 3.98 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.